Covered recipient · General Payments record
MATTHEW M MAY
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2019–2024
$897.63
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.36 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $182.91 | 3 |
| ABBVIE INC. | $177.84 | 4 |
| Galderma Laboratories, L.P. | $59.09 | 3 |
| MERZ NORTH AMERICA, INC. | $25.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104988286 | CMS |
| ABBVIE INC. | $9.28 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104988288 | CMS |
| ABBVIE INC. | $25.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104988290 | CMS |
| ABBVIE INC. | $18.19 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104988292 | CMS |
| Galderma Laboratories, L.P. | $20.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315243 | CMS |
| Galderma Laboratories, L.P. | $17.52 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315245 | CMS |
| Galderma Laboratories, L.P. | $21.21 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315247 | CMS |
| MERZ NORTH AMERICA, INC. | $25.52 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146373020 | CMS |
| REVANCE THERAPEUTICS, INC. | $146.52 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924114 | CMS |
| REVANCE THERAPEUTICS, INC. | $7.77 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924116 | CMS |
| REVANCE THERAPEUTICS, INC. | $28.62 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924118 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.